Obesity is a chronic condition, and your prescription medication is a tool for long-term management
It can take up to 16 weeks or more to reach your maintenance dose
Some people remain on maintenance for three to six months or longer before deciding whether a slightly higher dose would unlock additional progress
[1] [2] When treatment is interrupted for extended periods, the body may lose its adaptation to the medication, and restarting at a full maintenance dose could increase the risk of gastrointestinal symptoms
Option 3: Accept some waste The most practical approach: reconstitute the full 5 mg vial, use 4 microdoses over 28 days, and discard the remainder
In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol